Peli BioThermal Expands Frankfurt Service Center to Triple Capacity for Pharmaceutical Cold Chain Operations

Peli BioThermal, the global leader in temperature-controlled packaging solutions, has completed the expansion of its Frankfurt Service Center, tripling its...

October 21, 2025 | Tuesday | News
Adcytherix Raises €105 Million Series A to Advance Next-Generation Antibody–Drug Conjugates with Novel Payloads

Adcytherix Raises EUR 105M Series A to Accelerate Breakthrough Antibody-Drug Conjugate Pipeline with Strategic Focus on Novel Payloads Financing led b...

October 20, 2025 | Monday | News
Agios Pharmaceuticals Receives CHMP Positive Opinion for PYRUKYND® in Treating Alpha- and Beta-Thalassemia

Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rar...

October 20, 2025 | Monday | News
MilliporeSigma to Acquire JSR Life Sciences’ Chromatography Business to Strengthen Biologics Purification Capabilities

Acquisition aims to strengthen company’s downstream process offering of advanced filtration and chromatography solutions JSR’s innovativ...

October 16, 2025 | Thursday | News
French Biotech EVerZom Raises €10 Million to Launch First Clinical Trial of Exosome Therapy EVerGel™

Through this funding round, the company will initiate the clinical development of its first therapeutic candidate, EVerGel, in 2026, and will enhance its...

October 16, 2025 | Thursday | News
NuCana’s NUC-3373 Plus Pembrolizumab Shows Durable Responses in Heavily Pre-Treated Cancer Patients

NUC-3373 Plus Pembrolizumab Continues to Show Favorable Efficacy and Safety Profile in Heavily Pre-treated Patients Latest Data Cut-Off Shows Patient wi...

October 16, 2025 | Thursday | News
Quotient Sciences and Biorasi Partner to Streamline Early Clinical Trials from IND to Proof-of-Concept

Quotient Sciences, a leading global drug development, research and manufacturing accelerator, and Biorasi, a global clinical research organization (CRO),...

October 15, 2025 | Wednesday | News
Rein Therapeutics Receives EMA Approval to Launch Phase 2 RENEW Trial of LTI-03 in Germany and Poland

EMA approval covers study sites in Germany and Poland as part of the Company’s global Phase 2 RENEW trial Trial will evaluate LTI-03, a first-in...

October 13, 2025 | Monday | News
Greenwich LifeSciences Expands Phase III FLAMINGO-01 Breast Cancer Trial to Austria

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-0...

October 10, 2025 | Friday | News
Sai Life Sciences, Agility Life Sciences, and Centrix Pharma Solutions Form Integrated CMC Partnership

Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), Agility Life Sciences, and Centrix Pharma Solutions today announced the launch of an Integrated CMC ...

October 09, 2025 | Thursday | News
Roquette Unveils Novel Excipient KLEPTOSE® Crysmeb to Advance Drug Solubility and Delivery Performance

Roquette, a global leader in plant-based ingredients and pharmaceutical excipients for the health and nutrition sectors, today, celebrates the launch of ...

October 09, 2025 | Thursday | News
Axplora Announces €100 Million Global Investment to Strengthen API Manufacturing Leadership

Axplora, a global leader in small molecule API manufacturing and a trusted partner to the world’s most innovative pharmaceutical companies, today ann...

October 09, 2025 | Thursday | News
Lupin’s €190 Million Vision: Thierry Volle on Building a Global Ophthalmology Powerhouse

The €190 million acquisition of VISUfarma marks a pivotal moment in Lupin’s transformation into a global specialty-led biopharma. With VISUfarma...

October 08, 2025 | Wednesday | Interaction
MannKind Completes Acquisition of scPharmaceuticals to Strengthen Cardiometabolic Portfolio and Accelerate Growth

MannKind Corporation (Nasdaq: MNKD) successfully completed the previously announced acquisition of scPharmaceuticals Inc. The acquisition of scPhar...

October 08, 2025 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close